🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

10x Genomics, Inc.

TXG Healthcare
$22.33 +$0.28 (1.27%)
Market Cap: $2.85 B
Gurus Holding
6
Popularity Rank
#1402
% of Shares Held
13.37%
Net Activity (Q4 2025)
+$22.3 M

Guru Ownership Trend

Guru Analysis for 10x Genomics, Inc. (TXG)

10x Genomics, Inc. (TXG), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $381.48 M.

Top institutional holders include Catherine Wood and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $22.3 M net inflow during the quarter.

Recent activity highlights Joel Greenblatt who increased their stake by 400.3%. Conversely, Cliff Asness reduced exposure by 5.4%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$25.34 M
Total Buy Value
New Buys 2
Additions 3
-$3.03 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
2
Net Buyers
5

FAQs for 10x Genomics, Inc. (TXG)

Major holders include Catherine Wood ($206.6 M), Cliff Asness ($41.86 M), Renaissance Technologies (RenTech) ($25.29 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 17.08 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $22.3 M, with 5 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited TXG. The total reported sell value was $3.03 M.

Yes, 2 managers opened new positions in TXG, and 3 increased their existing holdings. The total reported buy value was $25.34 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.37% Add 6.6% 12,667,369 $206.6 M Q4 2025
0.02% Reduce -5.4% 2,579,051 $41.86 M Q4 2025
0.04% Add 48.4% 1,550,539 $25.29 M Q4 2025
0.01% New Buy 177,734 $2.9 M Q4 2025
0.01% Add 400.3% 94,717 $1.54 M Q4 2025
0.00% New Buy 14,299 $233,217 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form